The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,890.00
Bid: 1,875.00
Ask: 1,910.00
Change: -25.00 (-1.31%)
Spread: 35.00 (1.867%)
Open: 1,860.00
High: 1,890.00
Low: 1,860.00
Prev. Close: 1,915.00
SUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

12 Feb 2016 07:00

RNS Number : 8299O
S & U PLC
12 February 2016
 

 12 February 2016

 

 

S&U plc

("S&U", "the Company" or "the Group")

 

YEAR END TRADING UPDATE

 

 

S&U plc, the motor finance and specialist lender, today issues a trading update for the period from its Trading Statement of 10 December 2015 to the Company's year-end on 31 January 2016.

 

S&U is pleased to announce that current trading remains strong and in line with market expectations; it will announce its final results on 22 March 2016.

 

Current Trading

Advantage Finance our motor finance business continues to produce record results. Live customer numbers are now around 32,500 up over 32% on the same time last year and budgeted new transactions for the year were exceeded comfortably. This reflects the investment during the past financial year of £27m into developing our motor finance business.

 

New refinements to our already highly sophisticated underwriting systems have allowed Advantage to deepen our understanding of our traditional customers. This leads to even more opportunities for the higher margin, high quality business which has been Advantage's hallmark. As a result an expanded book of excellent quality is reflected in monthly collections which are now approaching £7m.

 

Acquisitions

We continue to examine potential acquisition and start up opportunities in a rigorous and painstaking way and have added to our development team. The recent reverses in stock market values have confirmed our impression of unrealistic pricing last year and may lead to better value in the coming months. Our search continues, but against a background of continuing investment in Advantage, and our determination to maintain shareholder returns in areas where we have experience and expertise.

 

Funding and Treasury

Notwithstanding the payment to shareholders of £14.9m by way of a special dividend last November, the financial position of the Group remains very strong. Net borrowings of just £12m are covered by committed facilities of £70m leaving significant headroom for the right acquisition and organic growth.

 

Dividend

The strength of current trading, future prospects and the Group's robust treasury position justifies the Board's approval of a second interim dividend of 23p per ordinary share (2015:19p) on Friday 18th March 2016 to holders on the share register on the 26th February 2016. The first and second dividends paid this year will therefore total 43p against 36p last year an increase of 19%.

 

Commenting on the Group trading and outlook, Anthony Coombs, Chairman of S&U plc said:

"Although the slight rise in real incomes in Britain over the past year has led to greater consumer confidence, particularly in the car market, current economic uncertainties will place a premium on those finance companies possessing the best underwriting systems and highest debt quality.

 

Coupled with a more stable political and regulatory environment, that will continue to reward the business methods and customer focus for which Advantage Finance is rightly admired".

 

 

 

For further information, please contact:

 

S&U plc - www.suplc.co.uk

Anthony Coombs, Chairman

0121 705 7777

Broker & Financial Advisor

Chris HardieArden Partners

 

0207 614 5917

Media and Investor Relations

Will Swan

Smithfield

0207 360 4900

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFWFLFFMSELE
Date   Source Headline
9th Apr 20247:00 amRNSPreliminary Unaudited FY Results to 31 Jan 24
25th Mar 20247:00 amRNSResults Presentations for Analysts and Investors
9th Feb 20247:00 amRNSTrading Statement and Notice of Results
1st Feb 20242:30 pmRNSNotice of Trading Update
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTrading Statement to 11 December 2023
31st Oct 20232:29 pmRNSDirector/PDMR and PCA Shareholding
5th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20237:00 amRNSInterim Results for the 6 months to 31 July 2023
4th Sep 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSTrading Update and Notice of Results
25th Jul 202311:34 amRNSDirector/PDMR Shareholding
17th Jul 20233:34 pmRNSDirector/PDMR Shareholding
26th May 20234:38 pmRNSDirector/PDMR Shareholding
25th May 202312:43 pmRNSResult of AGM
25th May 20237:00 amRNSAGM Statement and Trading Update
25th Apr 20232:00 pmRNSAnnual Report and Accounts
25th Apr 202311:48 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSMello Investor Presentation
6th Apr 20234:08 pmRNSAnnouncement of Annual Report and Accounts
28th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Mar 20237:00 amRNSPreliminary Results
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSResults Presentations for Analysts and Investors
14th Feb 20232:00 pmRNSAppointment of Executive Director
9th Feb 20237:00 amRNSTrading Statement and Notice of Results
8th Dec 20227:00 amRNSTrading Statement
27th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSResults Presentations for Analysts and Investors
18th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20227:00 amRNSTrading Update and Notice of Results
3rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
8th Jul 20225:06 pmRNSDirector/PDMR and PCA Shareholding
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 202212:33 pmRNSResult of AGM
26th May 20227:00 amRNSAGM Statement and Trading Update
23rd May 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
18th May 202211:30 amRNSOptions, Director/PDMR Shareholding, Voting Rights
13th May 20224:33 pmRNSDirector/PDMR Shareholding
5th May 20221:53 pmRNSDirector/PDMR Shareholding, Options, Voting Rights
26th Apr 20222:00 pmRNSAnnual Report and Accounts
4th Apr 20227:00 amEQSEdison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow
4th Apr 20227:00 amRNSAnnual Report and Accounts
29th Mar 20227:00 amRNSPreliminary Results
9th Mar 20227:00 amRNSResults Presentations for Analysts and Investors
10th Feb 20227:00 amRNSTrading Statement and Notice of Results
17th Jan 20222:39 pmRNSAppointment of non-executive director
17th Jan 20222:33 pmRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.